Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
291. |
ECCT/19/05/02 | ETNA EVALUATION OF TECHNOLOGIES FOR NEONATES IN AFRICA |
Principal Investigator(s) 1. PROF WILLIAM MAINA MACHARIA Site(s) in Kenya 1. AGA KHAN UNIVERSITY HOSPITAL (Nairobi City county) 2. PUMWANI MATERNITY HOSPITAL (Nairobi City county) |
View |
292. |
ECCT/19/08/02 | LOxaF- N Trial LOW DOSE OXYTOCIN AS AN ADJUNCT TO FOLEY CATHETER FOR CERVICAL RIPENING IN NULLIPAROUS WOMEN AT MTRH, ELDORET, KENYA: A RANDOMISED CONTROLLED TRIAL. |
Principal Investigator(s) 1. Patrick Omondi Otieno Site(s) in Kenya The Riley Mother and Baby Hospital (RMBH) at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. |
View |
293. |
ECCT/19/04/04 | Effectiveness of an integrated programme to reduce maternal and child malnutrition in Kenya Effectiveness of an integrated programme to reduce maternal and child malnutrition in Kenya:two cluster-randomized controlled trials in pregnant women and their offspring and in 6-59 months old children comparing an agricultural intervention alone with a combined agricultural, nutrition and WASH intervention. |
Principal Investigator(s) 1. Rita Wegmuller Site(s) in Kenya 1. Kakamega and Bungoma (Kakamega county) |
View |
294. |
ECCT/19/04/02 | NADIA \"Nucleosides And Darunavir/Dolutegravir In Africa\" A randomised controlled trial of darunavir versus dolutegravir and tenofovir versus zidovudine in second-line antiretroviral therapy regimens for the public health approach in sub-Saharan Africa |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya Moi University Clinical Research Centre |
View |
295. |
ECCT/19/04/03 | Phase III pediatric study with the L-PZQ ODTs An Open-label, Phase 3 efficacy and safety study of L-praziquantel orodispersible tablets (L-PZQ ODT) in Schistosoma-infected children 3 months to 6 years of age, including a 2:1 randomized, controlled cohort of Schistosoma mansoni-infected children 4 to 6 years of age treated with L-PZQ ODT or commercial PZQ (Biltricide®) |
Principal Investigator(s) 1. Maurice Reuben Odiere Site(s) in Kenya KEMRI-Centre for Global Health Research (CGHR) |
View |